{"id":108279,"date":"2025-01-08T15:57:43","date_gmt":"2025-01-08T08:57:43","guid":{"rendered":"https:\/\/hmm88i.com\/drug\/?post_type=product&p=108279"},"modified":"2025-07-24T13:22:44","modified_gmt":"2025-07-24T06:22:44","slug":"trajenta-duo-25mg-850mg","status":"publish","type":"product","link":"https:\/\/hmm88i.com\/drug\/trajenta-duo-25mg-850mg\/","title":{"rendered":"Trajenta Duo 2,5mg\/850mg"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n s\u1ea3n ph\u1ea9m thu\u1ed1c Trajenta Duo 2,5mg\/850mg<\/a> \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi Boehringer Ingelheim Promeco S.A. de C.V, c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 750110167400<\/strong><\/p>\n

Trajenta Duo 2,5mg\/850mg l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n

Th\u00e0nh ph\u1ea7n<\/h3>\n

Thu\u1ed1c Trajenta Duo 2,5mg\/850mg<\/strong> c\u00f3 ch\u1ee9a th\u00e0nh ph\u1ea7n:<\/p>\n

    \n
  • Linagliptin 2,5mg<\/li>\n
  • Metformin hydrochloride 850mg<\/li>\n
  • T\u00e1 d\u01b0\u1ee3c v\u1eeba \u0111\u1ee7 1 vi\u00ean<\/li>\n<\/ul>\n

    D\u1ea1ng b\u00e0o ch\u1ebf: Vi\u00ean n\u00e9n bao phim<\/p>\n

    Tr\u00ecnh b\u00e0y<\/h3>\n

    S\u0110K: 750110167400<\/p>\n

    Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 1 l\u1ecd 14 vi\u00ean; H\u1ed9p 1 l\u1ecd 60 vi\u00ean<\/p>\n

    Xu\u1ea5t x\u1ee9: Mexico<\/p>\n

    T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Trajenta Duo 2,5mg\/850mg<\/h2>\n

    C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n

    Linagliptin, m\u1ed9t ch\u1ea5t \u1ee9c ch\u1ebf DPP-4 ch\u1ecdn l\u1ecdc cao, ho\u1ea1t \u0111\u1ed9ng b\u1eb1ng c\u00e1ch \u1ee9c ch\u1ebf s\u1ef1 ph\u00e2n h\u1ee7y c\u1ee7a c\u00e1c hormone incretin nh\u01b0 GLP-1 v\u00e0 GIP. \u0110i\u1ec1u n\u00e0y d\u1eabn \u0111\u1ebfn t\u0103ng n\u1ed3ng \u0111\u1ed9 v\u00e0 k\u00e9o d\u00e0i th\u1eddi gian t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c hormone n\u00e0y, t\u1eeb \u0111\u00f3 t\u0103ng c\u01b0\u1eddng b\u00e0i ti\u1ebft insulin ph\u1ee5 thu\u1ed9c glucose v\u00e0 \u1ee9c ch\u1ebf b\u00e0i ti\u1ebft glucagon, c\u1ea3i thi\u1ec7n ki\u1ec3m so\u00e1t \u0111\u01b0\u1eddng huy\u1ebft.<\/p>\n

    Metformin l\u00e0 m\u1ed9t biguanide c\u00f3 t\u00e1c d\u1ee5ng h\u1ea1 \u0111\u01b0\u1eddng huy\u1ebft \u0111a chi\u1ec1u. Thu\u1ed1c gi\u1ea3m s\u1ea3n sinh glucose \u1edf gan th\u00f4ng qua \u1ee9c ch\u1ebf qu\u00e1 tr\u00ecnh gluconeogenesis v\u00e0 glycogenolysis. \u0110\u1ed3ng th\u1eddi, metformin t\u0103ng c\u01b0\u1eddng s\u1eed d\u1ee5ng glucose \u1edf ngo\u1ea1i bi\u00ean b\u1eb1ng c\u00e1ch c\u1ea3i thi\u1ec7n \u0111\u1ed9 nh\u1ea1y c\u1ea3m v\u1edbi insulin v\u00e0 \u1ee9c ch\u1ebf h\u1ea5p thu glucose \u1edf ru\u1ed9t.<\/p>\n

    \u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n\n\n\n\n\n\n\n\n
    D\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/strong><\/td>\nLinagliptin<\/strong><\/td>\nMetformin<\/strong><\/td>\n<\/tr>\n
    H\u1ea5p thu<\/td>\nSinh kh\u1ea3 d\u1ee5ng kho\u1ea3ng 30%.<\/p>\n

    C\u00f3 th\u1ec3 d\u00f9ng c\u00f9ng ho\u1eb7c kh\u00f4ng c\u00f9ng v\u1edbi th\u1ee9c \u0103n.<\/td>\n

    		Sinh kh\u1ea3 d\u1ee5ng 50-60%.<\/p>\n

    H\u1ea5p thu kh\u00f4ng ho\u00e0n to\u00e0n, c\u00f3 th\u1ec3 b\u00e3o h\u00f2a.<\/td>\n<\/tr>\n

    Ph\u00e2n b\u1ed1<\/td>\nR\u1ed9ng r\u00e3i \u0111\u1ebfn c\u00e1c m\u00f4.<\/p>\n

    Li\u00ean k\u1ebft protein huy\u1ebft t\u01b0\u01a1ng ph\u1ee5 thu\u1ed9c n\u1ed3ng \u0111\u1ed9.<\/td>\n

    		Kh\u00f4ng g\u1eafn \u0111\u00e1ng k\u1ec3 v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng.<\/p>\n

    Ph\u00e2n b\u1ed1 v\u00e0o h\u1ed3ng c\u1ea7u.<\/td>\n<\/tr>\n

    Chuy\u1ec3n h\u00f3a<\/td>\nChuy\u1ec3n h\u00f3a \u00edt.<\/p>\n

    Ch\u1ea5t chuy\u1ec3n h\u00f3a ch\u00ednh kh\u00f4ng c\u00f3 ho\u1ea1t t\u00ednh d\u01b0\u1ee3c l\u00fd.<\/td>\n

    		Kh\u00f4ng c\u00f3 ch\u1ea5t chuy\u1ec3n h\u00f3a \u1edf ng\u01b0\u1eddi.<\/td>\n<\/tr>\n
    Th\u1ea3i tr\u1eeb<\/td>\nQua ph\u00e2n (80%) v\u00e0 n\u01b0\u1edbc ti\u1ec3u (5%).<\/p>\n

    Thanh th\u1ea3i qua th\u1eadn kho\u1ea3ng 70ml\/ph\u00fat.<\/td>\n

    		Ho\u00e0n to\u00e0n qua th\u1eadn d\u01b0\u1edbi d\u1ea1ng kh\u00f4ng \u0111\u1ed5i.<\/p>\n

    Thanh th\u1ea3i qua th\u1eadn >400ml\/ph\u00fat.<\/td>\n<\/tr>\n

    \u1ea2nh h\u01b0\u1edfng c\u1ee7a b\u1ec7nh l\u00fd<\/td>\nSuy gan\/th\u1eadn: Kh\u00f4ng c\u1ea7n ch\u1ec9nh li\u1ec1u<\/td>\nSuy th\u1eadn: C\u1ea7n \u0111i\u1ec1u ch\u1ec9nh li\u1ec1u<\/p>\n

    Suy gan: Kh\u00f4ng c\u1ea7n ch\u1ec9nh li\u1ec1u<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Thu\u1ed1c Trajenta Duo 2,5mg\/850mg \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n

    Thu\u1ed1c Trajenta Duo<\/strong> 2.5mg\/850mg \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh nh\u01b0 m\u1ed9t li\u1ec7u ph\u00e1p k\u1ebft h\u1ee3p \u0111\u1ec3 c\u1ea3i thi\u1ec7n ki\u1ec3m so\u00e1t \u0111\u01b0\u1eddng huy\u1ebft \u1edf b\u1ec7nh nh\u00e2n ti\u1ec3u \u0111\u01b0\u1eddng type 2 tr\u01b0\u1edfng th\u00e0nh, bao g\u1ed3m nh\u1eefng b\u1ec7nh nh\u00e2n ch\u01b0a \u0111\u1ea1t \u0111\u01b0\u1ee3c m\u1ee5c ti\u00eau ki\u1ec3m so\u00e1t \u0111\u01b0\u1eddng huy\u1ebft khi \u0111i\u1ec1u tr\u1ecb b\u1eb1ng metformin \u0111\u01a1n tr\u1ecb ho\u1eb7c khi k\u1ebft h\u1ee3p linagliptin v\u00e0 metformin ri\u00eang l\u1ebb.<\/p>\n

    Ngo\u00e0i ra, thu\u1ed1c Trajenta Duo 2,5mg\/850mg c\u00f2n \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh k\u1ebft h\u1ee3p v\u1edbi sulfonylurea \u0111\u1ec3 t\u0103ng c\u01b0\u1eddng hi\u1ec7u qu\u1ea3 \u0111i\u1ec1u tr\u1ecb \u1edf nh\u1eefng b\u1ec7nh nh\u00e2n ch\u01b0a ki\u1ec3m so\u00e1t t\u1ed1t \u0111\u01b0\u1eddng huy\u1ebft.<\/p>\n

    Li\u1ec1u d\u00f9ng c\u1ee7a thu\u1ed1c Trajenta Duo 2,5mg\/850mg<\/h2>\n

    Thu\u1ed1c Trajenta Duo 2,5mg\/850mg n\u00ean \u0111\u01b0\u1ee3c u\u1ed1ng nguy\u00ean vi\u00ean c\u00f9ng v\u1edbi b\u1eefa \u0103n, v\u00e0 n\u00e2ng li\u1ec1u t\u1eeb t\u1eeb theo ch\u1ec9 d\u1eabn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 gi\u1ea3m thi\u1ec3u c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 l\u00ean \u0111\u01b0\u1eddng ti\u00eau h\u00f3a.<\/p>\n

    \"Thu\u1ed1c
    Thu\u1ed1c Trajenta Duo 2,5mg\/850mg d\u00e0nh cho \u0111\u1ed1i t\u01b0\u1ee3ng n\u00e0o?<\/figcaption><\/figure>\n

    Li\u1ec1u d\u00f9ng<\/p>\n\n\n\n\n\n\n\n\n\n\n\n
    \u0110\u1ed1i t\u01b0\u1ee3ng<\/td>\nLi\u1ec1u kh\u1edfi \u0111\u1ea7u<\/td>\nLi\u1ec1u t\u1ed1i \u0111a<\/td>\n<\/tr>\n
    M\u1edbi d\u00f9ng metformin<\/td>\n1 vi\u00ean Trajenta Duo 2,5mg\/850mg x 2 l\u1ea7n\/ng\u00e0y<\/td>\n5mg linagliptin\/ 2000mg metformin<\/td>\n<\/tr>\n
    Ch\u01b0a ki\u1ec3m so\u00e1t \u0111\u01b0\u1eddng huy\u1ebft t\u1ed1t v\u1edbi Metformin \u0111\u01a1n tr\u1ecb<\/td>\nLinagliptin 2,5mg x 2 l\u1ea7n\/ng\u00e0y<\/p>\n

    Metformin: duy tr\u00ec li\u1ec1u hi\u1ec7n t\u1ea1i<\/td>\n<\/tr>\n

    Chuy\u1ec3n t\u1eeb ph\u1ed1i h\u1ee3p Linagliptin v\u00e0 Metformin ri\u00eang l\u1ebb<\/td>\nB\u1eaft \u0111\u1ea7u \u1edf li\u1ec1u \u0111ang d\u00f9ng<\/td>\n<\/tr>\n
    Ch\u01b0a ki\u1ec3m so\u00e1t \u0111\u01b0\u1eddng huy\u1ebft t\u1ed1t v\u1edbi Metformin v\u00e0 Sulfonylurea<\/td>\nLinagliptin 2,5mg x 2 l\u1ea7n\/ng\u00e0y<\/p>\n

    Metformin: duy tr\u00ec li\u1ec1u hi\u1ec7n t\u1ea1i<\/p>\n

    Sulfonylurea: c\u00f3 th\u1ec3 gi\u1ea3m li\u1ec1u<\/td>\n<\/tr>\n

    Suy th\u1eadn (CrCl 45-59 mL\/ph\u00fat)<\/td>\nMetformin t\u1ed1i \u0111a 500mg x 2 l\u1ea7n\/ng\u00e0y<\/td>\n5mg linagliptin\/ 1000mg metformin<\/td>\n<\/tr>\n
    Ng\u01b0\u1eddi cao tu\u1ed5i<\/td>\nTheo li\u1ec1u khuy\u1ebfn c\u00e1o<\/td>\n5mg linagliptin\/ 2000mg metformin<\/td>\n<\/tr>\n
    Suy gan<\/td>\nCh\u1ed1ng ch\u1ec9 \u0111\u1ecbnh<\/td>\n–<\/td>\n<\/tr>\n
    Tr\u1ebb em v\u00e0 thanh thi\u1ebfu ni\u00ean<\/td>\nKh\u00f4ng khuy\u1ebfn c\u00e1o<\/td>\n–<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Kh\u00f4ng s\u1eed d\u1ee5ng thu\u1ed1c Trajenta Duo 2,5mg\/850mg trong tr\u01b0\u1eddng h\u1ee3p n\u00e0o?<\/h2>\n

    Thu\u1ed1c Trajenta Duo 2,5mg\/850mg<\/strong> kh\u00f4ng d\u00f9ng cho:<\/p>\n